|
Univariate analysis
| | | |
|
Gender (male vs. female)
|
0.422
|
0.232-0.770
|
0.005*
|
|
Age (< 46 vs. ≥ 46)
|
1.721
|
1.085-2.729
|
0.021*
|
|
WHO type (I vs. IV)
|
1.025
|
0.618-1.700
|
0.925
|
|
Clinical stage (I + II vs. III + IV)
|
1.824
|
1.012-3.286
|
0.045*
|
|
T stage (T1~2 vs. T3~4)
|
1.571
|
0.972-2.540
|
0.065
|
|
N stage (N0 vs. N1~3)
|
0.936
|
0.568-1.544
|
0.796
|
|
Recurrence (no vs. yes)
|
1.442
|
0.895-2.322
|
0.132
|
|
Metastasis (no vs. yes)
|
2.466
|
1.412-4.304
|
0.002*
|
|
LMP1 expression (low vs. high)
|
1.863
|
1.091-3.183
|
0.023*
|
|
p-mTOR expression (low vs. high)
|
1.274
|
0.796-2.040
|
0.314
|
|
p-P70S6K expression (low vs. high)
|
1.447
|
0.907-2.309
|
0.121
|
|
p-4EBP1 expression (low vs. high)
|
1.920
|
1.154-3.195
|
0.012*
|
|
Multivariate analysis
| | | |
|
Gender (male vs. female)
|
0.447
|
0.234-0.851
|
0.014*
|
|
Metastasis (no vs. yes)
|
2.591
|
1.383-4.856
|
0.003*
|
|
LMP1 expression (low vs. high)
|
2.056
|
1.161-3.641
|
0.013*
|
